Resultados de búsqueda - Thomas, Alissa
- Mostrando 1 - 20 Resultados de 24
- Ir a la Siguiente Página
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Anti–N-Methyl-D-Aspartate Receptor Encephalitis: A Patient With Refractory Illness After 25 Months of Intensive Immunotherapy por Thomas, Alissa, Rauschkolb, Paula, Gresa-Arribas, Núria, Schned, Alan, Dalmau, Josep O., Fadul, Camilo E.
Publicado 2013Texto -
9
-
10
-
11
INNV-10. SAFETY OF APIXABAN FOR VENOUS THROMBOEMBOLISM PREVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA por Thomas, Alissa, Wright, Heather, Walker, Hannah, Prasad, Prachi, Chan, Kelly, Tipirneni, Eswar, Goodwin, Andrew, Holmes, Chris
Publicado 2019Texto -
12
-
13
Intradural cauda equina Candida abscess presenting with hydrocephalus: case report por Argersinger, Davis P., Natkha, Vitaliy P., Shepard, Matthew J., Thomas, Alissa A., Oler, Andrew J., Williamson, Peter R., Chittiboina, Prashant, Heiss, John D.
Publicado 2019Texto -
14
CLRM-13 RELEVANCE OF RECURSIVE PARTITIONING ANALYSIS (RPA) CLASSIFICATION IN THE CURRENT CARE OF PATIENTS WITH BRAIN METASTASES (BMETS) por Sarai, Guneet, Amidon, Ryan F, Bovi, Joesph A, Thomas, Alissa A, Novicoff, Wendy, Schuetz, Samantha, Singh, Rohit, Chang, Amy, Sheehan, Jason P, Fadul, Camilo E
Publicado 2022Texto -
15
Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients por Zhang, Myron, Gulotta, Bryanna, Thomas, Alissa, Kaley, Thomas, Karimi, Sasan, Gavrilovic, Igor, Woo, Kaitlin M., Zhang, Zhigang, Arevalo-Perez, Julio, Holodny, Andrei I., Rosenblum, Marc, Young, Robert J.
Publicado 2016Texto -
16
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect por Ades, Steven, Herrera, Diego Adrianzen, Lahey, Tim, Thomas, Alissa A., Jasra, Sakshi, Barry, Maura, Sprague, Julian, Dittus, Kim, Plante, Timothy B., Kelly, Jamie, Kaufman, Peter A., Khan, Farrah, Hammond, Cory J., Gernander, Kelly, Parsons, Polly, Holmes, Chris
Publicado 2022Texto -
17
SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology por Chukwueke, Ugonma N, Vera, Elizabeth, Acquaye, Alvina, Hervey-Jumper, Shawn L, Odia, Yazmin, Klesse, Laura J, Dunbar, Erin, Sharma, Akanksha, Fonkem, Ekokobe, Thomas, Alissa A, Werbowetski-Ogilvie, Tamra E, Camelo-Piragua, Sandra, Gatson, Na Tosha N, de la Fuente, Macarena I, Armstrong, Terri S, Porter, Alyx B, Jackson, Sadhana
Publicado 2021Texto -
18
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma por Thomas, Alissa A., Fisher, Jan L., Rahme, Gilbert J., Hampton, Thomas H., Baron, Udo, Olek, Sven, Schwachula, Tim, Rhodes, C. Harker, Gui, Jiang, Tafe, Laura J., Tsongalis, Gregory J., Lefferts, Joel A., Wishart, Heather, Kleen, Jonathan, Miller, Michael, Whipple, Chery A., de Abreu, Francine B., Ernstoff, Marc S., Fadul, Camilo E.
Publicado 2015Texto -
19
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma por Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.
Publicado 2019Texto -
20
COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT por Mrugala, Maciej, Ostrom, Quinn, Pressley, Shelley, Thomas, Alissa, Wefel, Jeffrey S, Coven, Scott, Acquaye, Alvina, Haynes, Chas, Agnihotri, Sameer, Lim, Michael, Peters, Katherine, Butowski, Nicholas, Hervey-Jumper, Shawn, Porter, Alyx, Oliver, Kathy, Dunbar, Erin, Taylor, Jennie, Schiff, David, Nassiri, Farshad, Hegi, Monika, Armstrong, Terri, van den Bent, Martin, Chang, Susan, Zadeh, Gelareh, Chheda, Milan
Publicado 2020Texto